David currently has joined LSE Innovation as Head of Innovation in June 2020.

Previously, David worked as Chief Innovation Officer and Director of the Office of Innovation and Commercialization at the University of Hawaii System (UH), which he joined in March 2018. He was chairman of the International Strategy Committee at AUTM (Association of University Technology Managers) from 2017 to 2019, and chaired AUTM Asia Conference in 2017 which was held in Hong Kong. Prior to Hawaii, he was Director of Knowledge Transfer at the City University of Hong Kong, 2014-2018. He also worked for Stanford’s Office of Technology Licensing for six years, managing inventions while spearheading Stanford’s technology marketing effort in China.

From 2001 to 2006, David was Vice President Chief Advisor at Hitachi Corporate VC, where he scored two successful acquisitions and one IPO among the four VC investments he led.  

He founded an award-winning e-healthcare business in Beijing, and as CEO he secured $6M VC investment in the first foreign-invested cancer center in Shanghai which is now thriving. In the 1990s, he was Corporate VP at Varian Medical (NYSE: VAR), VP of Marketing at Cirque (acquired by ALPS Japan), and a Project Manager at Hewlett-Packard.

David received a BS in psychology from National Taiwan University, an MS in computer science from Indiana University, an MBA from Stanford University, and a JD from Santa Clara University. 

He recently co-authored a book, Commercialization of IP rights in China, published by American Bar Association (2020). He is a registered patent attorney (California), and an international expert in the diverse areas of innovation, law, business, technology, intellectual property, and startup entrepreneurship as well as VC investments.